These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19245509)

  • 1. When the heart and the mind collide: cardiovascular risk factors and antipsychotic use in the schizophrenic population.
    Halpert S; McFarlane SI
    J Cardiometab Syndr; 2009; 4(1):1-5. PubMed ID: 19245509
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 4. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic and cardiovascular adverse effects of modern antipsychotic agents].
    Andreassen OA; Bentsen H
    Tidsskr Nor Laegeforen; 2004 Jan; 124(2):181-2. PubMed ID: 14743232
    [No Abstract]   [Full Text] [Related]  

  • 6. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study].
    Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
    Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804
    [No Abstract]   [Full Text] [Related]  

  • 9. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
    Hrdlicka M; Zedkova I; Blatny M; Urbanek T
    Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain and first-generation antipsychotics: experience from a developing country.
    Yoon CK
    J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Schizophrenia: adverse effects of atypical neuroleptics].
    Bettina Polk B
    Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there an anti-fat bias among schizophrenia patients?
    Pierson KE
    Obesity (Silver Spring); 2006 Dec; 14(12):2305. PubMed ID: 17189559
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction: weighing the evidence: weight management insights for treating major mental illness.
    Citrome L
    J Clin Psychiatry; 2007; 68 Suppl 12():4. PubMed ID: 17956149
    [No Abstract]   [Full Text] [Related]  

  • 14. Eating-behavior changes associated with antipsychotic medications in patients with schizophrenia as measured by the drug-related eating behavior questionnaire.
    Ryu S; Nam HJ; Oh S; Park T; Lim M; Choi JS; Baek JH; Jang JH; Park HY; Kim SN; Joo YH; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2013 Feb; 33(1):120-2. PubMed ID: 23277254
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight gain, antipsychotic drug treatment and pharmacogenomics.
    Reynolds GP
    Pharmacogenomics; 2002 Sep; 3(5):567-70. PubMed ID: 12223042
    [No Abstract]   [Full Text] [Related]  

  • 16. Foreword. Importance of physical health in patients with schizophrenia.
    Höschl C
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S1-2. PubMed ID: 20620880
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic-induced weight gain in patients with schizophrenia.
    Llewellyn DJ; Naughton F
    JAMA; 2008 Apr; 299(16):1898-9; author reply 1899-900. PubMed ID: 18430905
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of weight management interventions for people with serious mental illness who receive treatment with atypical antipsychotic medications. A literature review.
    Lowe T; Lubos E
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):857-63. PubMed ID: 19012677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medical comorbidity on medication management of schizophrenia.
    Haupt DW
    CNS Spectr; 2007 Dec; 12(12 Suppl 21):15-7. PubMed ID: 18389928
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsychotic agents and cardiometabolic morbidity in youth.
    Kruszewski SP; Paczynski RP
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):394-5; author reply 395. PubMed ID: 19349574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.